Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Apr 6;101(14):5002-7.
doi: 10.1073/pnas.0400945101. Epub 2004 Mar 26.

The mutator pathway is a feature of immunodeficiency-related lymphomas

Affiliations

The mutator pathway is a feature of immunodeficiency-related lymphomas

Alex Duval et al. Proc Natl Acad Sci U S A. .

Abstract

The mutator phenotype caused by defects in the mismatch repair system is observed in a subset of solid neoplasms characterized by widespread microsatellite instability-high (MSI-H). It is known to be very rare in non-Hodgkin lymphomas (NHL), whereas mutator NHL is the most frequent tumor subtype in mismatch repair-deficient mice. By screening a series of 603 human NHL with specific markers of the mutator phenotype, we found here 12 MSI-H cases (12/603, 2%). Of interest, we demonstrated that this phenotype was specifically associated with immunodeficiency-related lymphomas (ID-RL), because it was observed in both posttransplant lymphoproliferative disorders (9/111, 8.1%) and HIV infection-related lymphomas (3/128, 2.3%) but not in a large series of NHL arising in the general population (0/364) (P < 0.0001). The MSI pathway is known to lead to the production of hundreds of abnormal protein neoantigens that are generated in MSI-H neoplasms by frameshift mutations of a number of genes containing coding microsatellite sequences. As expected, MSI-H ID-RL were found to harbor such genetic alterations in 12 target genes with a putative role in lymphomagenesis. The observation that the MSI-H phenotype was restricted to HIV infection-related lymphomas and posttransplant lymphoproliferative disorders suggests the existence of the highly immunogenic mutator pathway as a novel oncogenic process in lymphomagenesis whose role is favored when host immunosurveillance is reduced. Because MSI-H-positive cases were found to be either Epstein-Barr virus-positive or -negative, the mutator pathway should act synergistically or not with this other oncogenic factor, playing an important role in ID-RL.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Allelic profiles of Bat-26 and -25 obtained by multiplex fluorescent PCR of both these markers are shown for the 12 MSI-H NHL cases. In all cases, both normal alleles (from contaminating normal DNA) and shorter alleles (from tumor DNA) are present.
Fig. 2.
Fig. 2.
Examples of monomorphic allelic profiles of Bat-26 and -25 in four non-MSI NHL are shown.

References

    1. Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) Nature 368, 258-261. - PubMed
    1. Papadopoulos, N., Nicolaïdes, N. C., Wei, Y. F., Ruben, S. M., Carter, K. C., Rosen, C. A., Haseltine, W. A., Fleishmann, R. D., Fraser, C. M., Adams, M. D., et al. (1994) Science 263, 1625-1629. - PubMed
    1. Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M. & Kolodner, R. (1993) Cell 75, 1027-1038. - PubMed
    1. Leach, F. S., Nicolaïdes, N. C., Papadopoulos, N., Liu, B., Jen, J., Parsons, R., Peltomaki, P., Sistonen, P., Aaltonen, L. A., Nyström-Lahti, M., et al. (1993) Cell 75, 1215-1225. - PubMed
    1. Ionov, Y., Peinado, M., Malkhosyan, S., Shibata, D. & Perucho, M. (1993) Nature 363, 558-561. - PubMed

Publication types